These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 171348)

  • 1. 5-Hydroxytryptophan and sleep in Down's syndrome.
    Petre-Quadens O; De Lee C
    J Neurol Sci; 1975 Nov; 26(3):443-53. PubMed ID: 171348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep EEG patterns in a case of Down's syndrome--before and after 5-HTP.
    Lee JC; Ornitz EM; Tanguay PE; Ritvo ER
    Electroencephalogr Clin Neurophysiol; 1969 Sep; 27(7):686. PubMed ID: 4187354
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-hydroxytryptophan (5-HTP) in Down's syndrome.
    Partington MW; MacDonald MR
    Dev Med Child Neurol; 1971 Jun; 13(3):362-72. PubMed ID: 4255254
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of 5-HTP in the treatment of Down's syndrome.
    Weise P; Koch R; Shaw KN; Rosenfeld MJ
    Pediatrics; 1974 Aug; 54(2):165-8. PubMed ID: 4277102
    [No Abstract]   [Full Text] [Related]  

  • 5. [Down's syndrome and serotonin].
    Oura T; Uemura I
    Saishin Igaku; 1968 Feb; 24(2):328-31. PubMed ID: 4239279
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of high doses of 5-hydroxytryptophan on a patient with trisomy 21. Clinical, chemical and EEG correlations.
    Bazelon M; Barnet A; Lodge A; Shelburne SA
    Brain Res; 1968 Nov; 11(2):397-411. PubMed ID: 4302675
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal of hypotonia in infants with Down's syndrome by administration of 5-hydroxytryptophan.
    Bazelon M; Paine RS; Coeiw VA; Hunt P; Houck JC; Mahanand D
    Lancet; 1967 May; 1(7500):1130-3. PubMed ID: 4164790
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of drug treatment for Down's syndrome persons.
    Share JB
    Am J Ment Defic; 1976 Jan; 80(4):388-93. PubMed ID: 2011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy with 5-hydroxytryptophan of Down's disease].
    Simonsson H
    Nord Med; 1969 Jul; 81(31):952-4. PubMed ID: 4241288
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicinal treatment for relief of hypotonia in Down's Syndrome.
    Griffiths MI
    Physiotherapy; 1976 Jan; 62(1):19-20. PubMed ID: 130644
    [No Abstract]   [Full Text] [Related]  

  • 11. Decreased arousals among healthy infants after short-term sleep deprivation.
    Franco P; Seret N; Van Hees JN; Scaillet S; Vermeulen F; Groswasser J; Kahn A
    Pediatrics; 2004 Aug; 114(2):e192-7. PubMed ID: 15286256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-hydroxytryptophan and pyridoxine. Their effects in young children with Down's syndrome.
    Pueschel SM; Reed RB; Cronk CE; Goldstein BI
    Am J Dis Child; 1980 Sep; 134(9):838-44. PubMed ID: 6447999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L -5-Hydroxytryptophan treatment of sleep terrors in children.
    Bruni O; Ferri R; Miano S; Verrillo E
    Eur J Pediatr; 2004 Jul; 163(7):402-7. PubMed ID: 15146330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness to stimulation during paradoxical sleep in infants.
    Dittrichová J; Paul K; Pavlíková E
    Early Hum Dev; 1977 Dec; 1(3):213-25. PubMed ID: 214288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep patterns in mental retardation: Down's syndrome.
    Clausen J; Sersen EA; Lidsky A
    Electroencephalogr Clin Neurophysiol; 1977 Aug; 43(2):183-91. PubMed ID: 69529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butoctamide hydrogen succinate and intensive learning sessions: effects on night sleep of Down's syndrome patients.
    Gigli GL; Grubar JC; Colognola RM; Amata MT; Pollicina C; Ferri R; Musumeci SA; Bergonzi P
    Sleep; 1987 Dec; 10(6):563-9. PubMed ID: 2963363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5-hydroxytryptophan on fragmentation of REM sleep in alcoholics.
    Zarcone VP; Hoddes E
    Am J Psychiatry; 1975 Jan; 132(1):74-6. PubMed ID: 233794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromyographic activity and sleep states in infants.
    Liefting B; Bes F; Fagioli I; Salzarulo P
    Sleep; 1994 Dec; 17(8):718-22. PubMed ID: 7701183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT antagonists suppress sleep and delay its restoration after 5-HTP in p-chlorophenylalanine-pretreated cats.
    Sallanon M; Buda C; Janin M; Jouvet M
    Eur J Pharmacol; 1982 Aug; 82(1-2):29-35. PubMed ID: 6215254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep patterns of Down's syndrome children: effects of butoctamide hydrogen succinate (BAHS) administration.
    Grubar JC; Gigli GL; Colognola RM; Ferri R; Musumeci SA; Bergonzi P
    Psychopharmacology (Berl); 1986; 90(1):119-22. PubMed ID: 2945221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.